Target intelligence / Profile preview

RNA, U6 small nuclear 1056, pseudogene (RNU6-1056P)

Target
RNU6-1056P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 1056, pseudogene (RNU6-1056P) is a **non-coding RNA pseudogene** annotated in the human genome[1][3]. Pseudogenes are genetic elements that have sequence similarity to known genes but have lost their protein-coding capability due to mutations, truncation, or other disruptive events[2][5]. While some pseudogenes can be transcribed and may have secondary regulatory functions—such as acting as decoys for microRNAs, generating non-coding RNAs influencing gene expression, or participating in competing endogenous RNA (ceRNA) networks—there is no evidence that RNU6-1056P plays a significant or well-characterized biological role[2][5]. It is not considered a therapeutic target, and its annotation primarily serves as a reference for genomic studies rather than biomedical or pharmacological interventions. In summary, **RNU6-1056P** is a pseudogene derived from U6 small nuclear RNA sequences; it is not a receptor, transporter, enzyme, or a targetable protein for drug action, and there is no data supporting its involvement in disease or its utility as a biomarker[1][2][3][5].

Other names
RNU6-1056P
02

Biological functions

Potential gene regulation via noncoding RNA mechanisms, but no validated or specific biological function
03

Disease associations

Other (no direct disease role assigned for RNU6-1056P; some pseudogenes generally may have context-dependent regulatory influences in cancer or other diseases but this is not established for this specific pseudogene)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1056, pseudogene (RNU6-1056P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1056, pseudogene (RNU6-1056P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call